bapineuzumab

Can Biogen Catch up to Merck in Alzheimer's Race?
Motley Fool
Wed, 03/12/14 - 02:58 pm
Biogen Idec
Merck
Alzheimer's disease
E2609
bapineuzumab
LY2886721
Eli Lilly
Tecfidera
Alzheimer's Disease Could Become the Next Frontier in Pharmaceutical Research
Motley Fool
Tue, 11/19/13 - 07:40 am
Alzheimer's disease
R&D
JNJ
Eli Lilly
Pfizer
Elan
General Electric
Vizamyl
Amyvid
bapineuzumab
solanezumab
Which Alzheimer's Fighter Will Benefit From a Boost in Federal Funding?
Motley Fool
Mon, 09/30/13 - 04:29 pm
Alzheimer's disease
LY2886721
Eli Lilly
MK-8931
Merck
bapineuzumab
JNJ
solanezumab
Gammagard
Baxter International
Merck Hopes Alzheimer's Drug Fares Better Than Competitors
TheStreet.com
Thu, 09/5/13 - 08:50 am
Merck
Alzheimer's disease
Pfizer
Eli Lilly
JNJ
bapineuzumab
solanezumab
BACE inhibitors
MK-8931
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
monoclonal antibodies
Roche
Herceptin
Rituxan
Avastin
GSK
Amgen
Eli Lilly
Bristol-Myers Squibb
Seattle Genetics
Adcetris
Kadcyla
bapineuzumab
Elan
JNJ
Pfizer
necitumumab
AbbVie
Humira
The Past, Present, and Future of Alzheimer’s Treatments
Motley Fool
Fri, 08/23/13 - 09:26 am
Alzheimer's disease
Aricept
Pfizer
Eisai
Actavis
Namenda
Eli Lilly
Forest Labs
bapineuzumab
JNJ
Elan
Perrigo Company
solanezumab
PBT2
Prana Biotechnology
J&J Says It Sells Final Stake in Elan for $332 Million
Bloomberg
Fri, 06/14/13 - 08:08 am
bapineuzumab
Elan
JNJ
After failed trials, J&J pivots to early-stage Alzheimer's
Reuters
Wed, 02/13/13 - 10:44 am
Alzheimer's disease
JNJ
bapineuzumab
J&J Ponders Elan Tie While Alzheimer Drug Future Reviewed
Bloomberg
Tue, 11/13/12 - 11:43 am
Elan
JNJ
Alzheimer's disease
bapineuzumab
Scientists plan to detail research on potential Alzheimer's treatments from Eli Lilly, Pfizer
Yahoo/AP
Mon, 10/8/12 - 10:38 am
Eli Lilly
Alzheimer's disease
Pfizer
bapineuzumab
solanezumab
Pfizer-J&J Alzheimer drug fails to stop mental decline but may slow brain plaque, studies find
Yahoo/AP
Tue, 09/11/12 - 11:57 am
Pfizer
JNJ
Alzheimer's disease
bapineuzumab
Why Was Bapi Moved Into Phase 3 Clinical Trials?
Forbes
Thu, 08/16/12 - 11:49 am
bapineuzumab
Alzheimer's disease
JNJ
Pfizer
Lilly Last Hope For Alzheimer’s As Pfizer, J&J Bow Out
Bloomberg
Wed, 08/8/12 - 11:01 am
Pfizer
Eli Lilly
JNJ
bapineuzumab
Alzheimer's disease
solanezumab
Baxter International
Gammagard
Elan Shares Drop After Alzheimer’s Drug Development Halted
Bloomberg
Tue, 08/7/12 - 11:44 am
Elan
Pfizer
JNJ
bapineuzumab
Alzheimer's disease
Pfizer-J&J Drop Alzheimer’s Drug Studies After Failure
Bloomberg
Mon, 08/6/12 - 07:51 pm
Alzheimer's disease
Pfizer
JNJ
bapineuzumab
Alzheimer’s Setback Makes Elan Takeover Bait To Biogen
Bloomberg
Fri, 07/27/12 - 08:17 am
Elan
Biogen Idec
Alzheimer's disease
M&A
bapineuzumab
Hopes dim for Alzheimer's trials after Pfizer failure
Reuters
Tue, 07/24/12 - 11:32 pm
Pfizer
Alzheimer's disease
Elan
JNJ
bapineuzumab
Pfizer, J&J, Elan Alzheimer's Drug Fails
TheStreet.com
Mon, 07/23/12 - 09:58 pm
Pfizer
JNJ
Elan
Alzheimer's disease
bapineuzumab
J&J-Pfizer Drug Long Shot Against Alzheimer’s
Bloomberg Businessweek
Wed, 07/11/12 - 09:48 am
Alzheimer's disease
Pfizer
JNJ
bapineuzumab
Survey shows dim faith in Lilly, Pfizer Alzheimer's drugs
Reuters
Wed, 06/20/12 - 11:48 am
Eli Lilly
Pfizer
Alzheimer's disease
solanezumab
bapineuzumab

Pages